ADORA2A and neoplasm: It has also been demonstrated in colorectal cancer cells that A2BR working synergically with A2AR, expressed in tumor-associated fibroblast, participated in the immune checkpoint dependent on NT5E/ADO to establish the immunosuppressive response characteristic of tumor cells [143].